TelemedicineNCT04444297
3D Telemedicine During COVID-19: Non-clinical Validation
A study testing 3D Telemedicine and 2D Telemedicine in people with Telemedicine and Surgery, Plastic, run by NHS Greater Glasgow and Clyde at 1 site in United Kingdom.
Trial summary
Telemedicine will be used as standard practice during the Covid Pandemic, in order to reduce clinician exposure to patients and potential high viral load, and reduce patient footfall in a hospital caring for Covid patients. Read more about this study
- Who is it for?
- Ages 16 to 75 yearsHealthy volunteers can take part
- Conditions the study is for
- Telemedicine, Surgery, Plastic
- What is being tested?
- 3D Telemedicine and 2D Telemedicine
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 40 participants
- Where
- 1 siteUnited Kingdom
- Study dates
- 1 Sep 2021to 31 Dec 2021
- Phase
- Interventional
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 16 to 75 years
- All sexes
- Healthy volunteers accepted
- Child, Adult, Older adult
Who may be able to join
- Healthy volunteers from staff at NHS GGC.
Who cannot join
- visual problems not correctable with glasses
- dyslexia.
Trial locations and contacts
1 site in 1 country.
United Kingdom1 site
Canniesburn Regional Plastic Surgery and Burns Unit
Glasgow, Scotland, G4 0SF
About this study
Telemedicine will be used as standard practice during the Covid Pandemic, in order to reduce clinician exposure to patients and potential high viral load, and reduce patient footfall in a hospital caring for Covid patients. The 3D telemedicine uses multiple cameras in the clinic room which can reconstruct an image in 3 dimensions. This may give more information about a patient's condition, particularly in more visual specialties such as Plastic Surgery. The systems have hospital approval to be used for telemedicine, all equipment is CE marked. There are no data regarding the use of 3D telemedicine, but similar studies have been performed in many fields including orthopaedic surgery using 2D telemedicine (Buvik 2016). This study aims to provide non-clinical validations of the 3D telemedicine for usability, presence, satisfaction and reliability, using healthy volunteers only.
Read the detailed description
Study Methods The study will involve non-clinical validation with no patients and no interventions. The study will investigate usability, presence, satisfaction and reliability data for 3D telemedicine, and provide subjective feedback in the form of a semi-structured interview.
Participants Healthy volunteers from the staff at Canniesburn Regional Plastic Surgery and Burns Unit, Glasgow Royal Infirmary and West Glasgow ACH, Greater Glasgow and Clyde.
Inclusions and exclusion Healthy staff/students. Recruitment from all contacted, eligible participants will be recorded. Exclusion criteria include visual problems not correctable with glasses/dyslexia.
Consent Participants will be consented in writing for inclusion in the study. The consent will specify that data may be recorded for research and further analysis by the research team, and be available for technical purposes by the research team's industrial partner
Sample Size
30-40 participants for Presence and Usability Questionnaires.
Participants will examine other participants (where one acts as a "doctor" and one acts as a "patient") to provide indicators of usability, presence and task load index. All participants will assess other participants using the screening tasks below (estimated 10 mins maximum):
Screening Tasks: asking "patient" to follow instructions Upper Limb: Functional screening upper limb - hands above head, brush teeth, hands behind back, pro-supination, wrist, prehension grips (power, span, pinch, key, tripod) Lower limb: Functional assessment of lower limb - walk, straight leg raise, take shoes off and examine sole of feet Head: examine worm's eye view of nose, side of nose and top of scalp.
Performing a "task" Perform a form of physiotherapy or equivalent task (chosen at random) such as describing to patient the use of an anterolateral thigh flap for tumour reconstruction.
Outcomes assessed: validated questionnaires, time taken to complete screening tasks, NASA task load index
Randomisation Participants will be randomized to see "patients" in 3D or 2D first. This will be by blocked randomisation using a list and sealed envelopes.
Outcome Measures
Multiple measures of usability and presence will be used. This will be to form baseline data on the 3D telemedicine system (e.g. System usability score >68 is "good"), but also to determine the sensitivity of the various instruments to record overall satisfaction with the systems. This will help to determine the most appropriate instruments for the clinical validation.
Mental Effort Rating Scale - single instrument Likert scale (Paas 1996) University of North Northway - 5 item - telemedicine questionnaire (Buvik 2016) System Usability Scale - 10 item scale - industry standard for usability of technology (Brooke 1986) Presence Questionnaire - 29 item scale - assessment of presence in the system/virtual environment (PQ, Witmer 2005).
Telehealth Usability Questionnaire - 21 item scale - assessment of telemedicine NASA TLX - task load index - 5 item modified scale - an indication of the ease of performing a task and frustration levels.
Overall Telemedicine Satisfaction - VAS Semi Structured exit interview - will discuss with participant their views on the telemedicine system and how we can improve.
Statistics and Analysis
The values obtained for the different rating scales will be summarised, in order to provide a basis for future sample size calculations. With a sample size of 40, the confidence interval around an estimated standard deviation s would be 0.819 s to 1.284 s. With a sample size of 50 it would be 0.835 s to 1.246 (Sim 2012).
The relation between the various rating scales and overall telemedicine satisfaction will be assessed using linear mixed effects regression analysis predicting overall telemedicine satisfaction from the rating scale and type of telemedicine, including a random effect for participant.
The research team will examine whether higher "presence" scores (on Presence Questionnaire) translate to less "frustration" (on NASA TLX), and whether this results in less error/time taken to complete tasks. This will be done using linear mixed effects regression analyses.
- Conditions
- Telemedicine, Surgery, Plastic
- Being tested
- 3D Telemedicine, 2D Telemedicine
- Keywords
- 3-D
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
3D TelemedicineOther
A consultation performed with a 3D form of telemedicine
2D TelemedicineOther
A consultation performed with 2D (standard) telemedicine
| Study group | Role | What they receive |
|---|---|---|
| 2D telemedicine | Active comparator | 2D telemedicine first, followed by crossover to 3D telemedicine with no washout period Receives: Other: 2D Telemedicine |
| 3D Telemedicine | Experimental | 3D telemedicine first, followed by crossover to 2D telemedicine with no washout period Receives: Other: 3D Telemedicine |
What is being measured
The primary outcome is the main question the study is designed to answer.
Presence Questionnaire
Version 3 of PQ, 29 item rating scale of "presence". Witmer 2005
Measured: Single time point at day 1 (Clinician assesses telemedicine system once after seeing patient) ]
University Hospital of North Northway Questionnaire
5 item questionnaire on telemedicine quality. UNN Buvik 2016.
Measured: Single time point at day 1 (Clinician assesses telemedicine system once after seeing patient)
Secondary outcomes (5)
Telehealth Usability Questionnaire
21 item scale - assessment of telemedicine (TUQ, Parmanto 2016)
Measured: Single time point at day 1 (Clinician assesses telemedicine system once after seeing patient) ]
System Usability Scale
10 item industry standard technology scale
Measured: Single time point at day 1 (Clinician assesses telemedicine system once after seeing patient) ]
Mental Effort Rating Scale
Single instrument Likert scale (Paas 1996)
Measured: Single time point at day 1 (Clinician assesses telemedicine system once after seeing patient) ]
NASA TLX
Measure of task load index - 5 item modified scale - an indication of the ease of performing a task and frustration levels.
Measured: Single time point at day 1 (Clinician assesses telemedicine system once after seeing patient) ]
Range of Motion measurements for elbow joint
Range of Motion measurements for elbow joint measured with face-to-face goniometer or on computer (telemedicine)
Measured: Single time point at day 1 (Clinician assesses telemedicine system once after seeing patient) ]
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted23 Jun 2020
- Study start1 Sep 2021 (estimated)
- Primary completion31 Dec 2021 (estimated)
- Study completion31 Dec 2021 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for TelemedicineStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Other
- Allocation
- Randomised
- Intervention model
- Crossover
- Model description
- Randomised to 2D then 3D, or 3D then 3D telemedicine consultations
- Masking
- Double blind
- Who is masked
- Investigator, Outcomes assessor
- Enrolment
- 40 participants (estimated)
Sponsor and investigators
- Lead sponsor
- NHS Greater Glasgow and Clyde
- Sponsor type
- University, hospital or other
- Collaborators
- Jean Brown Bequest Fund, Glasgow, UK
- Responsible party
- Sponsor
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT04444297
- Sponsor's protocol ID
- GN20HS287
- Status last verified
- Jun 2021
- First submitted
- 20 Jun 2020
- Last updated
- 8 Jun 2021
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No: No plan to share
Study at a glance
From the registry record, last updated by the sponsor on 8 Jun 2021. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- 3D Telemedicine During COVID-19: Non-clinical Validation
- ClinicalTrials.gov ID
- NCT04444297
- Acronym / sponsor ID
- GN20HS287
- Conditions
- Telemedicine, Surgery, Plastic
- Keywords
- 3-D
- Study type
- Interventional
- Recruitment status
- Unknown status
- Enrolment
- 40 participants (estimated)
- Lead sponsor
- NHS Greater Glasgow and ClydeUniversity, hospital or other
- Collaborators
- Jean Brown Bequest Fund, Glasgow, UK
- Study start
- 1 Sep 2021 (estimated)
- Primary completion
- 31 Dec 2021 (estimated)
- Study completion
- 31 Dec 2021 (estimated)
- First posted
- 23 Jun 2020 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
Telemedicine will be used as standard practice during the Covid Pandemic, in order to reduce clinician exposure to patients and potential high viral load, and reduce patient footfall in a hospital caring for Covid patients. The 3D telemedicine uses multiple cameras in the clinic room which can reconstruct an image in 3 dimensions. This may give more information about a patient's condition, particularly in more visual specialties such as Plastic Surgery. The systems have hospital approval to be used for telemedicine, all equipment is CE marked. There are no data regarding the use of 3D telemedicine, but similar studies have been performed in many fields including orthopaedic surgery using 2D telemedicine (Buvik 2016). This study aims to provide non-clinical validations of the 3D telemedicine for usability, presence, satisfaction and reliability, using healthy volunteers only.
Detailed description
Study Methods The study will involve non-clinical validation with no patients and no interventions. The study will investigate usability, presence, satisfaction and reliability data for 3D telemedicine, and provide subjective feedback in the form of a semi-structured interview.
Participants Healthy volunteers from the staff at Canniesburn Regional Plastic Surgery and Burns Unit, Glasgow Royal Infirmary and West Glasgow ACH, Greater Glasgow and Clyde.
Inclusions and exclusion Healthy staff/students. Recruitment from all contacted, eligible participants will be recorded. Exclusion criteria include visual problems not correctable with glasses/dyslexia.
Consent Participants will be consented in writing for inclusion in the study. The consent will specify that data may be recorded for research and further analysis by the research team, and be available for technical purposes by the research team's industrial partner
Sample Size
30-40 participants for Presence and Usability Questionnaires.
Participants will examine other participants (where one acts as a "doctor" and one acts as a "patient") to provide indicators of usability, presence and task load index. All participants will assess other participants using the screening tasks below (estimated 10 mins maximum):
Screening Tasks: asking "patient" to follow instructions Upper Limb: Functional screening upper limb - hands above head, brush teeth, hands behind back, pro-supination, wrist, prehension grips (power, span, pinch, key, tripod) Lower limb: Functional assessment of lower limb - walk, straight leg raise, take shoes off and examine sole of feet Head: examine worm's eye view of nose, side of nose and top of scalp.
Performing a "task" Perform a form of physiotherapy or equivalent task (chosen at random) such as describing to patient the use of an anterolateral thigh flap for tumour reconstruction.
Outcomes assessed: validated questionnaires, time taken to complete screening tasks, NASA task load index
Randomisation Participants will be randomized to see "patients" in 3D or 2D first. This will be by blocked randomisation using a list and sealed envelopes.
Outcome Measures
Multiple measures of usability and presence will be used. This will be to form baseline data on the 3D telemedicine system (e.g. System usability score >68 is "good"), but also to determine the sensitivity of the various instruments to record overall satisfaction with the systems. This will help to determine the most appropriate instruments for the clinical validation.
Mental Effort Rating Scale - single instrument Likert scale (Paas 1996) University of North Northway - 5 item - telemedicine questionnaire (Buvik 2016) System Usability Scale - 10 item scale - industry standard for usability of technology (Brooke 1986) Presence Questionnaire - 29 item scale - assessment of presence in the system/virtual environment (PQ, Witmer 2005).
Telehealth Usability Questionnaire - 21 item scale - assessment of telemedicine NASA TLX - task load index - 5 item modified scale - an indication of the ease of performing a task and frustration levels.
Overall Telemedicine Satisfaction - VAS Semi Structured exit interview - will discuss with participant their views on the telemedicine system and how we can improve.
Statistics and Analysis
The values obtained for the different rating scales will be summarised, in order to provide a basis for future sample size calculations. With a sample size of 40, the confidence interval around an estimated standard deviation s would be 0.819 s to 1.284 s. With a sample size of 50 it would be 0.835 s to 1.246 (Sim 2012).
The relation between the various rating scales and overall telemedicine satisfaction will be assessed using linear mixed effects regression analysis predicting overall telemedicine satisfaction from the rating scale and type of telemedicine, including a random effect for participant.
The research team will examine whether higher "presence" scores (on Presence Questionnaire) translate to less "frustration" (on NASA TLX), and whether this results in less error/time taken to complete tasks. This will be done using linear mixed effects regression analyses.
Study design
- Primary purpose
- Other
- Allocation
- Randomised
- Intervention model
- Crossover
- Masking
- Double blind (investigator, outcomes assessor)
- Number of arms
- 2
- Model description
- Randomised to 2D then 3D, or 3D then 3D telemedicine consultations
| Arm | Type | Receives |
|---|---|---|
| 2D telemedicine | Active comparator | Other: 2D Telemedicine2D telemedicine first, followed by crossover to 3D telemedicine with no washout period |
| 3D Telemedicine | Experimental | Other: 3D Telemedicine3D telemedicine first, followed by crossover to 2D telemedicine with no washout period |
Who may qualify
- Ages
- 16 to 75 years
- Sex
- All
- Healthy volunteers
- Accepted
- Age groups
- Child, Adult, Older adult
Key inclusion criteria (1 listed)
- Healthy volunteers from staff at NHS GGC.
Key exclusion criteria (2 listed)
- visual problems not correctable with glasses
- dyslexia.
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| 3D TelemedicineA consultation performed with a 3D form of telemedicine | Other | 3D Telemedicine |
| 2D TelemedicineA consultation performed with 2D (standard) telemedicine | Other | 2D telemedicine |
Primary outcome
Presence Questionnaire
Time frame: Single time point at day 1 (Clinician assesses telemedicine system once after seeing patient) ]
Version 3 of PQ, 29 item rating scale of "presence". Witmer 2005
University Hospital of North Northway Questionnaire
Time frame: Single time point at day 1 (Clinician assesses telemedicine system once after seeing patient)
5 item questionnaire on telemedicine quality. UNN Buvik 2016.
5 secondary outcomes
Telehealth Usability Questionnaire
Time frame: Single time point at day 1 (Clinician assesses telemedicine system once after seeing patient) ]
System Usability Scale
Time frame: Single time point at day 1 (Clinician assesses telemedicine system once after seeing patient) ]
Mental Effort Rating Scale
Time frame: Single time point at day 1 (Clinician assesses telemedicine system once after seeing patient) ]
NASA TLX
Time frame: Single time point at day 1 (Clinician assesses telemedicine system once after seeing patient) ]
Range of Motion measurements for elbow joint
Time frame: Single time point at day 1 (Clinician assesses telemedicine system once after seeing patient) ]
Results and safety
Results are not available in the source record.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 8 Jun 2021.
- Individual participant dataSharing planned: No. No plan to share
Related trials for Telemedicine
Recruiting
Public Perceptions Toward Robotic Surgery, Telesurgery and Telemedicine
Robotic Surgery, Telemedicine
Recruiting
A Pragmatic Clinical Trial of the WE BEAT Well-Being Education Program in Adolescent Congenital Heart Disease: WE BEAT CHD Study
Patient-Reported Outcome Measures (PROMs), Pragmatic Trial
Recruiting
Feasibility and Effectiveness of Tele-diabetes Remote System on Glycemic Control and Quality of Life of Children and Youth With Type 1 Diabetes
Diabetes Mellitus, Type 1 Diabetes, Mobile Health Platform
Enrolling by invitationObservational study
Clinical Time and Temporal Dynamics Study (CLIN-TIME)
Longitudinal Studies, Prospective Studies
Recruiting
Pilot Testing of the emPath Platform to Improve Medication for Opioid Use Disorder (MOUD) Linkage and Retention Among Adults With Opioid Use Disorder in Durham, North Carolina
Opioid Use Disorder, Digital Health Intervention
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
The record lists no contact. Use the official record to reach the sponsor.
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing 3D Telemedicine and 2D Telemedicine in people with Telemedicine and Surgery, Plastic, run by NHS Greater Glasgow and Clyde at 1 site in United Kingdom.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 1 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: status not confirmed, as of the sponsor's last update on 8 Jun 2021. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in United Kingdom. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
Results are not available in the source record.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Presence Questionnaire (time frame: Single time point at day 1 (Clinician assesses telemedicine system once after seeing patient) ]). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 8 Jun 2021; AzTrials last refreshed its copy on 6 Nov 2026.